Vanguard Group Inc Entrada Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,604,860 shares of TRDA stock, worth $8.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,604,860
Previous 1,575,594 1.86%
Holding current value
$8.47 Million
Previous $14.2 Million 24.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$6.72 - $9.23 $196,667 - $270,125
29,266 Added 1.86%
1,604,860 $10.8 Million
Q1 2025

May 09, 2025
BUY
$9.04 - $18.31 $1.01 Million - $2.04 Million
111,357 Added 7.61%
1,575,594 $14.2 Million
Q4 2024

Feb 11, 2025
BUY
$15.82 - $21.59 $3.81 Million - $5.2 Million
241,052 Added 19.71%
1,464,237 $25.3 Million
Q3 2024

Nov 13, 2024
BUY
$13.65 - $17.86 $1.28 Million - $1.67 Million
93,562 Added 8.28%
1,223,185 $19.6 Million
Q2 2024

Aug 13, 2024
BUY
$11.85 - $16.45 $600,972 - $834,261
50,715 Added 4.7%
1,129,623 $16.1 Million
Q1 2024

May 10, 2024
BUY
$11.58 - $17.0 $159,132 - $233,614
13,742 Added 1.29%
1,078,908 $15.3 Million
Q4 2023

Feb 14, 2024
BUY
$11.36 - $16.99 $509,484 - $761,984
44,849 Added 4.4%
1,065,166 $16.1 Million
Q3 2023

Nov 14, 2023
BUY
$13.61 - $18.01 $143,830 - $190,329
10,568 Added 1.05%
1,020,317 $16.1 Million
Q2 2023

Aug 14, 2023
BUY
$11.02 - $18.01 $893,545 - $1.46 Million
81,084 Added 8.73%
1,009,749 $15.3 Million
Q1 2023

May 15, 2023
BUY
$9.58 - $16.2 $80,586 - $136,274
8,412 Added 0.91%
928,665 $13.5 Million
Q4 2022

Feb 10, 2023
BUY
$13.52 - $22.89 $677,433 - $1.15 Million
50,106 Added 5.76%
920,253 $12.4 Million
Q3 2022

Nov 14, 2022
BUY
$9.65 - $15.76 $1.04 Million - $1.7 Million
107,783 Added 14.14%
870,147 $13.7 Million
Q2 2022

Aug 12, 2022
BUY
$5.49 - $12.94 $1.82 Million - $4.3 Million
331,960 Added 77.13%
762,364 $9.29 Million
Q1 2022

May 13, 2022
BUY
$7.99 - $16.93 $43,561 - $92,302
5,452 Added 1.28%
430,404 $4.04 Million
Q4 2021

Feb 14, 2022
BUY
$13.7 - $35.0 $5.82 Million - $14.9 Million
424,952 New
424,952 $7.27 Million

Others Institutions Holding TRDA

# of Institutions
107
Shares Held
28.8M
Call Options Held
15.7K
Put Options Held
0
View Full List

About Entrada Therapeutics, Inc.

TRDA Quotes by TradingView
  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $166M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email